Vital Biopharmaceutical Insights and Analytics

for Experts from Experts

Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.

Learn More

FEATURED PRODUCT
Community-Acquired Bacterial Pneumonia

Rib-X’s radezolid will be the only agent to launch for community-acquired bacterial pneumonia over the next decade... Learn More

WEBINAR ON DEMAND
European Physician and Payer Perspectives on Immune-Targeted Agents in Rheumatoid Arthritis

Recorded live on January 19, 2012 ...Learn More

View Webinar schedule and archive

Search Reports

TOP TEN REPORTS

See which reports have been searched on the most.

Go

In the Spotlight

oncology-spotlight.gif
 

Join Decision Resources Group in San Francisco on March 8th for this exciting one-day seminar.  Expert analysts from Decision Resources Group will cover a range of industry and therapeutic-specific issues, addressing the hottest topics in oncology.

Learn more.

 

Recent Reports [ view all ]

  • Acute Coronary Syndrome (Event Driven)

    Last Updated 24 January 2012
    Acute coronary syndrome (ACS)—an umbrella term encompassing acute ST-elevation... Read More

  • Hepatitis C Virus (Event Driven)

    Last Updated 23 January 2012
    Hepatitis C virus (HCV) is marked by a relatively large prevalent population... Read More

  • Alzheimer's Disease (Event Driven)

    Last Updated 23 January 2012
    The Alzheimer’s disease (AD) patient population is large and growing rapidly as... Read More

Decision Resources Group companies include: